Skip to content
10-Q

Quarterly Report

Oncology Institute, Inc. DFPH TOI TOIIW

0001799191-25-000036

← back to feed
Filed
Nov 13, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 6, 2025 98.38M sh
Shares Diluted Q3 2025 · Sep 30, 2025 97.47M sh
Shares Diluted Q3 2025 · Sep 30, 2025 89.33M sh
Shares Diluted Q3 2025 · Sep 30, 2024 75.52M sh
Shares Diluted Q3 2025 · Sep 30, 2024 74.84M sh
Capex Q3 2025 · Sep 30, 2025 $2.14M
Capex Q3 2025 · Sep 30, 2024 $2.03M
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$27.82M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$30.72M
Long Term Debt Q3 2025 · Sep 30, 2025 $76.2M
Long Term Debt Q3 2025 · Dec 31, 2024 $93.13M
Stockholders Equity Q3 2025 · Sep 30, 2025 −$12.27M
Stockholders Equity Q3 2025 · Jun 30, 2025 −$8.99M
Stockholders Equity Q3 2025 · Mar 31, 2025 $5.07M
Stockholders Equity Q3 2025 · Dec 31, 2024 $3.59M
Stockholders Equity Q3 2025 · Sep 30, 2024 $15.48M
Stockholders Equity Q3 2025 · Jun 30, 2024 $29.21M
Stockholders Equity Q3 2025 · Mar 31, 2024 $41.3M
Stockholders Equity Q3 2025 · Dec 31, 2023 $57.03M
Current Liabilities Q3 2025 · Sep 30, 2025 $65.58M
Current Liabilities Q3 2025 · Dec 31, 2024 $52.22M
Total Liabilities Q3 2025 · Sep 30, 2025 $175.89M
Total Liabilities Q3 2025 · Dec 31, 2024 $169.13M
Current Assets Q3 2025 · Sep 30, 2025 $110.09M
Current Assets Q3 2025 · Dec 31, 2024 $112.42M
Total Assets Q3 2025 · Sep 30, 2025 $163.62M
Total Assets Q3 2025 · Dec 31, 2024 $172.72M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.14
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.49
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.18
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.56
Eps Basic Q3 2025 · Sep 30, 2025 −$0.14
Eps Basic Q3 2025 · Sep 30, 2025 −$0.49
Eps Basic Q3 2025 · Sep 30, 2024 −$0.18
Eps Basic Q3 2025 · Sep 30, 2024 −$0.56
Sga Expense Q3 2025 · Sep 30, 2025 $25.25M
Sga Expense Q3 2025 · Sep 30, 2025 $77.53M
Sga Expense Q3 2025 · Sep 30, 2024 $26.65M
Sga Expense Q3 2025 · Sep 30, 2024 $82.97M
Net Income Q3 2025 · Sep 30, 2025 −$16.5M
Net Income Q3 2025 · Sep 30, 2025 −$53.1M
Net Income Q3 2025 · Jun 30, 2025 −$17.01M
Net Income Q3 2025 · Mar 31, 2025 −$19.59M
Net Income Q3 2025 · Sep 30, 2024 −$16.11M
Net Income Q3 2025 · Sep 30, 2024 −$51.48M
Net Income Q3 2025 · Jun 30, 2024 −$15.48M
Net Income Q3 2025 · Mar 31, 2024 −$19.89M
Operating Income Q3 2025 · Sep 30, 2025 −$8.05M
Operating Income Q3 2025 · Sep 30, 2025 −$29.18M
Operating Income Q3 2025 · Sep 30, 2024 −$13.85M
Operating Income Q3 2025 · Sep 30, 2024 −$48.19M
Revenue Q3 2025 · Sep 30, 2025 $136.56M
Revenue Q3 2025 · Sep 30, 2025 $360.77M
Revenue Q3 2025 · Sep 30, 2024 $99.9M
Revenue Q3 2025 · Sep 30, 2024 $293.15M